PMID- 30618575 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20201001 IS - 1662-4548 (Print) IS - 1662-453X (Electronic) IS - 1662-453X (Linking) VI - 12 DP - 2018 TI - Common Variants in PLXNA4 and Correlation to CSF-related Phenotypes in Alzheimer's Disease. PG - 946 LID - 10.3389/fnins.2018.00946 [doi] LID - 946 AB - The Plexin-A 4 (PLXNA4) gene, has recently been identified in genome wide association studies (GWAS), as a novel genetic player associated with Alzheimer's disease (AD). Additionally, PLXNA4 genetic variations were also found to increase AD risk by tau pathology in vitro. However, the potential roles of PLXNA4 variants in the amyloid-beta (Abeta) pathology, were not evaluated. Five targeted loci capturing the top common variations in PLXNA4, were extracted using tagger methods. Multiple linear regression models were used to explore whether these variations can affect the cerebrospinal fluid (CSF) (Abeta(1-42), T-tau, and P-tau) phenotypes in the Alzheimer's disease Neuroimaging Initiative (ADNI) dataset. We detected that two loci (rs6467431, rs67468325) were significantly associated with CSF Abeta(1-42) levels in the hybrid population (rs6467431: P = 0.01376, rs67468325: P = 0.006536) and the significance remained after false discovery rate (FDR) correction (rs6467431: Pc = 0.03441, rs67468325: Pc = 0.03268). In the subgroup analysis, we further confirmed the association of rs6467431 in the cognitively normal (CN) subgroup (P = 0.01904, Pc = 0.04761). Furthermore, rs6467431-A carriers and rs67468325-G carriers showed higher CSF Abeta(1-42) levels than non-carriers. Nevertheless, we did not detect any significant relationships between the levels of T-tau, P-tau and these PLXNA4 loci. Our findings provided preliminary evidence that PLXNA4 variants can confer AD risk through modulating the Abeta deposition. FAU - Han, Qiu AU - Han Q AD - Department of Neurology, Qingdao Clinical Medical School, Qingdao Municipal Hospital, Nanjing Medical University, Qingdao, China. AD - Department of Neurology, The Affiliated Huaian Hosipital of Xuzhou Medical University, Huai'an, China. FAU - Sun, Yong-An AU - Sun YA AD - Department of Neurology, Qingdao Clinical Medical School, Qingdao Municipal Hospital, Nanjing Medical University, Qingdao, China. AD - Department of Neurology, First Affiliated Hospital of Kangda School, Nanjing Medical University, Lianyungang, China. FAU - Zong, Yu AU - Zong Y AD - Department of Neurology, School of Medicine, Qingdao Municipal Hospital, Qingdao University, Qingdao, China. FAU - Chen, Chun AU - Chen C AD - Department of Neurology, Qingdao Clinical Medical School, Qingdao Municipal Hospital, Nanjing Medical University, Qingdao, China. AD - Department of Neurology, Hongze Huai'an District People's Hospital, Huai'an, China. FAU - Wang, Hui-Fu AU - Wang HF AD - Department of Neurology, School of Medicine, Qingdao Municipal Hospital, Qingdao University, Qingdao, China. FAU - Tan, Lan AU - Tan L AD - Department of Neurology, Qingdao Clinical Medical School, Qingdao Municipal Hospital, Nanjing Medical University, Qingdao, China. CN - Alzheimer's Disease Neuroimaging Initiative LA - eng GR - U01 AG024904/AG/NIA NIH HHS/United States PT - Journal Article DEP - 20181218 PL - Switzerland TA - Front Neurosci JT - Frontiers in neuroscience JID - 101478481 PMC - PMC6305543 OTO - NOTNLM OT - Alzheimer's disease (AD) OT - Plexin-A 4 (PLXNA4) OT - amyloid-beta (Abeta) OT - association OT - variant EDAT- 2019/01/09 06:00 MHDA- 2019/01/09 06:01 PMCR- 2018/01/01 CRDT- 2019/01/09 06:00 PHST- 2018/09/06 00:00 [received] PHST- 2018/11/29 00:00 [accepted] PHST- 2019/01/09 06:00 [entrez] PHST- 2019/01/09 06:00 [pubmed] PHST- 2019/01/09 06:01 [medline] PHST- 2018/01/01 00:00 [pmc-release] AID - 10.3389/fnins.2018.00946 [doi] PST - epublish SO - Front Neurosci. 2018 Dec 18;12:946. doi: 10.3389/fnins.2018.00946. eCollection 2018.